Outcomes of coronary revascularization (percutaneous or bypass) in patients with diabetes mellitus and multivessel coronary disease

American Journal of Cardiology

Volumn 110, Issue 5, 2012, Pages 643-648

  Hee, Leia ^a   Mussap, Christian J ^a,b   Yang, Lihua ^b   Dignan, Rebecca ^a,b   Kadappu, Krishna K ^a,b   Juergens, Craig P ^a,b   Thomas, Liza ^a,b   French, John K ^a,b  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; AUSTRALIA; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SCORING SYSTEM; STROKE;

AGE FACTORS; AGED; ANGIOPLASTY, BALLOON, CORONARY; CAUSE OF DEATH; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; NEW SOUTH WALES; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84864944402     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.04.043     Document Type: Article

References (31)

1. J.D. Flaherty, C.J. Davidson Diabetes and coronary revascularization JAMA 293 2005 1501 1508
2. J. Daemen, E. Boersma, M. Flather, J. Booth, R. Stables, A. Rodriguez, G. Rodriguez-Granillo, W.A. Hueb, P.A. Lemos, P.W. Serruys Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials Circulation 118 2008 1146 1154
3. S.J. Nicholls, E.M. Tuzcu, S. Kalidindi, K. Wolski, K.W. Moon, I. Sipahi, P. Schoenhagen, S.E. Nissen Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: A pooled analysis of 5 intravascular ultrasound trials J Am Coll Cardiol 52 2008 255 262
4. B. Marcheix, F. Vanden Eynden, P. Demers, D. Bouchard, R. Cartier Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery Ann Thorac Surg 86 2008 1181 1188
5. A. Abizaid, M.A. Costa, M. Centemero, A.S. Abizaid, V.M. Legrand, R.V. Limet, G. Schuler, F.W. Mohr, W. Lindeboom, A.G. Sousa, J.E. Sousa, B. van Hout, P.G. Hugenholtz, F. Unger, P.W. Serruys Arterial Revascularization Therapy Study Group Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial Circulation 104 2001 533 538
6. P.W. Serruys, Y. Onuma, S. Garg, G. Sarno, M. van den Brand, A.P. Kappetein, N. Van Dyck, M. Mack, D. Holmes, T. Feldman, M.C. Morice, A. Colombo, E. Bass, K. Leadley, K.D. Dawkins, G.A. van Es, M.A. Morel, F.W. Mohr Assessment of the SYNTAX score in the SYNTAX study EuroIntervention 5 2009 50 56
7. P.W. Serruys, M.C. Morice, A.P. Kappetein, A. Colombo, D.R. Holmes, M.J. Mack, E. Ståhle, T.E. Feldman, M. van den Brand, E.J. Bass, N. Van Dyck, K. Leadley, K.D. Dawkins, F.W. Mohr SYNTAX Investigators Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
8. G. Sianos, M.A. Morel, A.P. Kappetein, M.C. Morice, A. Colombo, K. Dawkins, M. van den Brand, N. Van Dyck, M.E. Russell, F.W. Mohr, P.W. Serruys The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease EuroIntervention 1 2005 219 227
9. R. Gulati, C.S. Rihal, B.J. Gersh The SYNTAX trial: A perspective Circ Cardiovasc Interv 2 2009 463 467
10. P.W. Serruys, F. Unger, J.E. Sousa, A. Jatene, H.J. Bonnier, J.P. Schönberger, N. Buller, R. Bonser, M.J. van den Brand, L.A. van Herwerden, M.A. Morel, B.A. van Hout Arterial Revascularization Therapies Study Group Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease N Engl J Med 344 2001 1117 1124
11. D. Capodanno, M.E. Di Salvo, G. Cincotta, M. Miano, C. Tamburino Usefulness of the syntax score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease Circ Cardiovasc Interv 2 2009 302 308
12. T. Chakravarty, M.H. Buch, H. Naik, A.J. White, N. Doctor, J. Schapira, J.M. Mirocha, G. Fontana, J.S. Forrester, R. Makkar Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization Am J Cardiol 107 2011 360 366
13. Y.H. Kim, D.W. Park, W.J. Kim, J.Y. Lee, S.C. Yun, S.J. Kang, S.W. Lee, C.W. Lee, S.W. Park, S.J. Park Validation of syntax (synergy between PCI with Taxus and cardiac surgery) score for prediction of outcomes after unprotected left main coronary revascularization JACC Cardiovasc Interv 3 2010 612 623
14. S.J. Brener, A.J. Prasad, R. Abdula, T.J. Sacchi Relationship between the angiographically derived syntax score and outcomes in high-risk patients undergoing percutaneous coronary intervention J Invasive Cardiol 23 2011 66 69
15. A.P. Kappetein, T.E. Feldman, M.J. Mack, M.C. Morice, D.R. Holmes, E. Ståhle, K.D. Dawkins, F.W. Mohr, P.W. Serruys, A. Colombo Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the syntax trial Eur Heart J 32 2011 2125 2134
16. S. Garg, G. Sarno, H.M. Garcia-Garcia, C. Girasis, J. Wykrzykowska, K.D. Dawkins, P.W. Serruys ARTS-II Investigators A new tool for the risk stratification of patients with complex coronary artery disease: the clinical SYNTAX score Circ Cardiovasc Interv 3 2010 317 326
17. M.J. Mack, A.P. Banning, P.W. Serruys, M.C. Morice, Y. Taeymans, G. Van Nooten, G. Possati, F. Crea, K.L. Hood, K. Leadley, K.D. Dawkins, A.P. Kappetein Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome Ann Thorac Surg 92 2011 2140 2146
18. S.B. King III, S.C. Smith Jr, J.W. Hirshfeld Jr, A.K. Jacobs, D.A. Morrison, D.O. Williams Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 writing group to review new evidence and update the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention, writing on behalf of the 2005 writing committee Circulation 2008 2007 261 295
19. M.R. Patel, G.J. Dehmer, J.W. Hirshfeld, P.K. Smith, J.A. Spertus ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography J Am Coll Cardiol 53 2009 530 553
20. R. Dörr [Bypass surgery versus percutaneous coronary intervention in patients with diabetes mellitus] Herz 35 2010 182 190
21. M.E. Farkouh, G. Dangas, M.B. Leon, C. Smith, R. Nesto, J.B. Buse, D.J. Cohen, E. Mahoney, L. Sleeper, S. King III, M. Domanski, S. McKinlay, V. Fuster Design of the future revascularization evaluation in patients with diabetes mellitus: optimal management of multivessel disease (FREEDOM) trial Am Heart J 155 2008 215 223
22. A.P. Banning, S. Westaby, M.C. Morice, A.P. Kappetein, F.W. Mohr, S. Berti, M. Glauber, M.A. Kellett, R.S. Kramer, K. Leadley, K.D. Dawkins, P.W. Serruys Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents J Am Coll Cardiol 55 2010 1067 1075
23. D.E. Cutlip, M.S. Chauhan, D.S. Baim, K.K. Ho, J.J. Popma, J.P. Carrozza, D.J. Cohen, R.E. Kuntz Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials J Am Coll Cardiol 40 2002 2082 2089
24. R. Iijima, R.A. Byrne, A. Dibra, G. Ndrepepa, C. Spaulding, G.J. Laarman, M. Menichelli, M. Valgimigli, E. Di Lorenzo, C. Kaiser Drug-eluting stents versus bare-metal stents in diabetic patients with st-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from 7 randomized trials Rev Esp Cardiol 62 2009 354 364
25. Y. Ben-Gal, Y. Moshkovitz, N. Nesher, G. Uretzky, R. Braunstein, A. Hendler, E. Zivi, I. Herz, R. Mohr Drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus Ann Thorac Surg 82 2006 1692 1697
26. N.W. Niles, P.D. McGrath, D. Malenka, H. Quinton, D. Wennberg, S.J. Shubrooks, J.F. Tryzelaar, R. Clough, M.J. Hearne, F. Hernandez Jr, M.W. Watkins, G.T. O'Connor Northern New England Cardiovascular Disease Study Group Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study Northern New England Cardiovascular Disease Study Group J Am Coll Cardiol 37 2001 1008 1015
27. National Institute for Health and Clinical Excellence Drug-eluting stents for the treatment of coronary artery disease http://www.nice.org.uk/TA152 2008 Accessed on October 2011.
28. New South Wales Health Greater Metropolitan Clinical Task Force (GMCT) Clinical guidelines for the use of drug eluting coronary artery stents in public hospitals in NSW http://www.health.nsw.gov.au/resources/gmct/cardic/drug- eluting-stents-pdf.asp 2008 Accessed on October 2011.
29. G.N. Levine, E.R. Bates, J.C. Blankenship, S.R. Bailey, J.A. Bittl, B. Cercek, C.E. Chambers, S.G. Ellis, R.A. Guyton, S.M. Hollenberg, U.N. Khot, R.A. Lange, L. Mauri, R. Mehran, I.D. Moussa, D. Mukherjee, B.K. Nallamothu, H.H. Ting 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary Circulation 124 2011 2574 2609
30. W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M.F. Piepoli, C. Pirlet, J.L. Pomar, N. Reifart, F.L. Ribichini, M.J. Schalij, P. Sergeant, P.W. Serruys, S. Silber, M. Sousa Uva, D. Taggart Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
31. L.D. Hillis, P.K. Smith, J.L. Anderson, J.A. Bittl, C.R. Bridges, J.G. Byrne, J.E. Cigarroa, V.J. DiSesa, L.F. Hiratzka, A.M. Hutter, M.E. Jessen, E.C. Keeley, S.J. Lahey, R.A. Lange, M.J. London, M.J. Mack, M.R. Patel, J.D. Puskas, J.F. Sabik, O. Selnes, D.M. Shahian, J.C. Trost, M.D. Winniford 2011 ACCF/AHA guideline for coronary artery bypass graft surgery Circulation 124 suppl 2011 e652 e735